AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV
ByAinvest
Friday, Jul 18, 2025 10:57 pm ET1min read
Processa Pharmaceuticals and BullFrog AI will be featured on Bloomberg TV's RedChip Small Stocks, Big Money show this Saturday. George Ng, CEO of Processa, will discuss the company's oncology drug development, lead asset PCS6422, and recent $7M capital infusion. Vin Singh, CEO of BullFrog AI, will highlight the company's AI platform, BullFrog Data Networks, and recent commercial expansion through a strategic alliance with Sygnature Discovery.
This Saturday, July 19, at 7 p.m. Eastern Time (ET), Bloomberg TV will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) and BullFrog AI, Inc. (Nasdaq: BFRG) on the RedChip Small Stocks, Big Money™ show. The interviews will provide insights into the companies' innovative approaches to drug development and their respective investment opportunities.George Ng, CEO of Processa Pharmaceuticals, will discuss the company's oncology drug development, focusing on its lead asset, PCS6422 (NGC-Cap), which is currently enrolling patients in a Phase 2 trial for metastatic breast cancer. Ng will also highlight Processa's Regulatory Science Approach, which aims to generate superior tumor-targeting drugs with significantly reduced toxicity. He will elaborate on the company's recent $7M capital infusion and its strategic partnership with Intact Therapeutics for PCS12852, as well as the realignment of its pipeline to prioritize assets with strong commercial and regulatory potential.
Vin Singh, CEO of BullFrog AI, will discuss the company's enterprise-ready AI platform, BullFrog Data Networks™, powered by the proprietary bfLEAP™ engine. Singh will explain how the company's multimodal, causal AI technology enables life sciences companies to uncover novel drug targets, optimize clinical trials, and repurpose existing therapies, thereby reducing development costs and timelines. He will also highlight BullFrog's recent commercial expansion through a strategic alliance with global CRO Sygnature Discovery, which is expected to generate up to $30 million in revenue by 2028, as well as exclusive research collaborations with institutions like the J. Craig Venter Institute and Lieber Institute.
Both companies are clients of RedChip Companies, an international investor relations, media, and research firm focused on microcap and small-cap companies. The interviews will be available in their entirety at the following links: PCSA [1] and BFRG [2].
References:
[1] https://www.redchip.com/assets/access/pcsa_access
[2] https://www.redchip.com/assets/access/bfrg_access.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet